Ownership Action To Observe: Georgetown Bancorp Inc (MD) Institutional Investors 2016 Q2 Sentiment

November 21, 2016 - By Linda Rogers   ·   0 Comments

Ownership Action To Observe: Georgetown Bancorp Inc (MD) Institutional Investors  2016 Q2 Sentiment

Sentiment for Georgetown Bancorp Inc (MD)

Georgetown Bancorp Inc (MD) institutional sentiment is 1 in 2016 Q2. Its the same as in 2016Q1. The ratio is neither positive nor negative, as only 3 investment managers opened new or increased positions, while 3 sold and reduced stock positions in Georgetown Bancorp Inc. The investment managers in our partner’s database now have: 466,677 shares, down from 966,162 shares in 2016Q1. Also, the number of investment managers holding Georgetown Bancorp Inc in their top 10 positions was flat from 0 to 0 for the same number . Sold All: 1 Reduced: 2 Increased: 1 New Position: 2.

MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The company has a market cap of $6.06 billion. The Company’s national network consists of approximately 3,240 affiliated physicians, including approximately 1,100 physicians who provide neonatal clinical care, in over 30 states and Puerto Rico, within hospital neonatal intensive care units , to babies born prematurely or with medical complications. It has a 17.51 P/E ratio. It has over 250 affiliated physicians who provide maternal-fetal care to expectant mothers experiencing complicated pregnancies and obstetrical hospitalist services in many areas where its affiliated neonatal physicians practice.

The stock decreased 0.76% or $0.49 on November 18, hitting $63.88. MEDNAX Inc (MD) has declined 6.93% since April 19, 2016 and is downtrending. It has underperformed by 10.80% the S&P500.

According to Zacks Investment Research, “Mednax, Inc., formerly Pediatrix Medical Group, Inc. is a healthcare services company that focuses on physician services for newborn, maternal-fetal, pediatric subspecialty and anesthesia care. The company ,through its subsidiaries, provides these services in the United States and Puerto Rico. In addition, MEDNAX engages in clinical research, monitoring clinical outcomes, and implementing clinical initiatives.”

MEDNAX Inc (NYSE:MD) Ratings Coverage

Ratings analysis reveals 50% of MEDNAX’s analysts are positive. Out of 2 Wall Street analysts rating MEDNAX, 1 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. MD was included in 2 notes of analysts from October 27, 2016. Mizuho maintained MEDNAX Inc (NYSE:MD) rating on Friday, October 28. Mizuho has “Buy” rating and $69.0 price target. Raymond James downgraded the stock to “Mkt Perform” rating in Thursday, October 27 report.

MD Company Profile

MEDNAX, Inc., incorporated on October 10, 2007, is a well-known provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The Company’s national network consists of approximately 3,240 affiliated physicians, including approximately 1,100 physicians who provide neonatal clinical care, in over 30 states and Puerto Rico, within hospital neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 1,150 affiliated physicians who provide anesthesia care to patients in connection with surgical and other procedures, as well as pain management. It has over 255 affiliated physicians who provide maternal-fetal care to expectant mothers experiencing complicated pregnancies and obstetrical hospitalist services in many areas where its affiliated neonatal physicians practice. The Company’s network also includes other pediatric subspecialists, including over 140 physicians providing pediatric cardiology care, 120 physicians providing pediatric intensive care, 100 physicians providing hospital pediatric care and approximately 20 physicians providing pediatric surgical care.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Linda Rogers

Tags: , ,


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>